Envoy Medical Enrolls First Three Participants In Final Stage In Pivotal Clinical Study Of Full Implanted Acclaim Cochlear Implant

Author: Benzinga Newsdesk | November 04, 2025 08:11am

Envoy Medical, Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that the first three patients have been enrolled in the final stage of the Company's pivotal clinical trial of the full implanted Acclaim® cochlear implant. These initial surgeries in this final stage were performed by Dr. Abraham Jacob at the Center for Neurosciences Ear and Hearing Center in Tucson, Arizona and Dr. Jack Shohet at Shohet Ear Associates in Seal Beach, California, two of the seven investigational sites in the United States.

Posted In: COCH